Addictions Therapeutics Market Competitive Strategy Analysis

1
Addictions Therapeutics Market Global Analysis
and Forecast to 2027

• Published Date Nov 2020

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com

• Addictions Therapeutics Market Forecast to 2027 -
  COVID-19 Impact and Global Analysis by Treatment
  Type (Opioid Addiction Treatment, Alcohol
  Addiction treatment, Nicotine Addiction
  treatment, Other substance addiction treatment)
  Drug Type (Nalaxone, Naltrexone, Bupropion,
  Disulfiram, Nicotine replacement products,
  Methadone, Varenicline) Treatment Center
  (Inpatient treatment center, Residential
  treatment Center, Outpatient Treatment Center)
  Distribution Channel (Hospital Pharmacies,
  Medical stores, Others) and Geography

3
Addictions Therapeutics Market Value
Email sales_at_theinsightpartners.com

• CAGR of 6.2
• (2020 to 2027)

4
Addictions Therapeutics Market Overview
Email sales_at_theinsightpartners.com

• The addictions therapeutics market was valued at
  US 6,691.01 million in 2019 and is projected to
  reach US 10,735.94 million by 2027 it is
  expected to grow at a CAGR of 6.2 from 2020 to
  2027.
• Addiction is a psychological and physical
  inability to stop consuming drugs, alcohol,
  opioids, and related category substances, even
  though the consumption of those substances causes
  various mental and physical harms. Addiction can
  be life-threatening if not stopped. Therefore,
  there are several options such as drug therapy
  and rehabilitation to stop addiction in a better
  way. Rising addictions among common people and
  increasing awareness campaigns drive the growth
  of the addictions therapeutics market. Moreover,
  the rising demand for RD from contract
  organizations is expected to bolster the market
  growth during the forecast period. However, steep
  costs of drug development restrict the market
  growth.

5
Key Segment Market
Email sales_at_theinsightpartners.com

• Segment By Type-
• Treatment Type (Opioid Addiction Treatment,
  Alcohol Addiction treatment, Nicotine Addiction
  treatment, Other substance addiction treatment)
• Drug Type (Nalaxone, Naltrexone, Bupropion,
  Disulfiram, Nicotine replacement products,
  Methadone, Varenicline)
• Treatment Center (Inpatient treatment center,
  Residential treatment Center, Outpatient
  Treatment Center)
• Distribution Channel (Hospital Pharmacies,
  Medical stores, Others)

6
Company Profiles
Email sales_at_theinsightpartners.com

• Indivior PLC
• Pfizer, Inc.
• GlaxoSmithKline Plc
• Bausch Health Companies
• Cipla, Inc.
• Orexo AB
• Purdue Pharma L.P.
• Alvogen
• Camurus AB
• Hikma Pharmaceuticals Plc

Download Sample Here
7
By Geography
Email sales_at_theinsightpartners.com

• North America (the US, Canada, and Mexico)
• Europe (the UK, Germany, France, Italy, Spain,
  and the Rest of Europe)
• Asia Pacific (China, Japan, India, Australia,
  South Korea, and the Rest of Asia Pacific)
• Middle East Africa (the UAE, Saudi Arabia,
  South Africa, and the Rest of Middle East
  Africa)
• South Central America (Brazil, Argentina, and
  the Rest of South Central America).

8
THANKYOU!

• Phone  [phone]

• E-Mail sales_at_theinsightpartners.com